ABSTRACT
Severe skin reactions/conditions are of particular concern when the traveler is away from home, and medical care is unfamiliar or of uncertain caliber. Perhaps the most signicant of these conditions is Stevens-Johnson syndrome, which may occur after the use of antimalarials such as Fansidar for prophylaxis while traveling in Africa. Travel remains a rapidly growing enterprise with more remote destinations appearing on the radar screen each year, making the previous review a basis for this update.1
